Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Federal Trade Commission
Chubb
US Department of Justice
McKinsey
Mallinckrodt

Generated: September 15, 2019

DrugPatentWatch Database Preview

Litigation for EXONDYS 51

  Try a free trial


See Plans and Pricing

« Back to Dashboard

US Court Litigation for EXONDYS 51

Patent Case Name Docket Date Filed Date Terminated Cause Court Jury Demand Link To Docket
8,486,907 ➤ Sign Up ➤ Sign Up 2016-02-25 2016-04-29 35:0146 Review of Board of Patent Appeals Decision District Court, D. Delaware None ➤ Sign Up
8,486,907 ➤ Sign Up ➤ Sign Up 2016-02-25 2016-04-29 35:0146 Review of Board of Patent Appeals Decision District Court, D. Delaware None ➤ Sign Up
>Patent >Case Name >Docket >Date Filed >Date Terminated >Cause >Court >Jury Demand >Link To Docket

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Johnson and Johnson
Citi
Cipla
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.